MYLAN-ABACAVIR/LAMIVUDINE

ਉਤਪਾਦ ਝਲਕ

About MYLAN-ABACAVIR/LAMIVUDINE

Mylan-Abacavir/Lamivudine is a prescription medication containing the active ingredients Abacavir (Abacavir Sulfate) and Lamivudine. It is used in the treatment of HIV-1 infection in combination with other antiretroviral agents.

Key Benefits & Uses

• Treatment of HIV-1 infection in combination with other antiretroviral agents.
• Reduction of viral load and improvement of immune function in HIV-1 infected patients.
• Prevention of HIV-1 disease progression and related complications.

Active Ingredient & Action

Abacavir (Abacavir Sulfate) and Lamivudine work by inhibiting the replication of the HIV-1 virus. Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) that interferes with the viral DNA synthesis, while Lamivudine is also an NRTI that inhibits the viral RNA-dependent DNA polymerase. By combining these two active ingredients, Mylan-Abacavir/Lamivudine effectively suppresses the HIV-1 virus, reducing the viral load and improving the immune function in infected patients.

Important Notes

It is essential to take Mylan-Abacavir/Lamivudine exactly as prescribed by your healthcare provider. Do not skip or miss doses, as this may lead to treatment failure or the development of drug resistance. Inform your healthcare provider about any medical conditions, allergies, or medications you are taking before starting treatment with Mylan-Abacavir/Lamivudine. Regular monitoring of your viral load and CD4 cell count is recommended to assess the effectiveness of the treatment and make necessary adjustments.